Daniel Skovronsky Myriad Genetics Inc (MYGN) insider trading activity

Daniel Skovronsky is Director of MYRIAD GENETICS INC. Currently has a direct ownership of 135,806 shares of MYGN, which is worth approximately $751,007. The most recent transaction as insider was on Jun 05, 2025, when has been sold 49,796 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 136K

57.9% 3M change

57.9% 12M change

Total Value Held $751,007

Daniel Skovronsky Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 05 2025	BUY Grant, award, or other acquisition	-	49,796 Added 26.83%	135,806 Common Stock
Jun 06 2024	BUY Grant, award, or other acquisition	-	15,695 Added 15.43%	86,010 Common Stock
Jun 01 2023	BUY Grant, award, or other acquisition	-	15,151 Added 17.73%	70,315 Common Stock
Jun 02 2022	BUY Grant, award, or other acquisition	-	17,275 Added 23.85%	55,164 Common Stock
Jun 03 2021	BUY Grant, award, or other acquisition	-	12,848 Added 25.32%	37,889 Common Stock
Dec 04 2020	BUY Grant, award, or other acquisition	-	15,889 Added 27.96%	40,930 Common Stock

Also insider at

LLY

ELI LILLY & Co Healthcare

EVP, CSO & Pres. LRL & LLY Imm